{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:15:39Z","timestamp":1777626939276,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012323","name":"CSIR - Indian Institute of Chemical Biology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009589","name":"Jadavpur University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["1-10\/2012"],"award-info":[{"award-number":["1-10\/2012"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.lfs.2023.121467","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T11:00:38Z","timestamp":1675249238000},"page":"121467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Assessment of superiority of HSP70-targeting aptamer-functionalized drug-nanocarrier over non-targeted commercially available counterpart in HCC therapy: in vitro and in vivo investigations and molecular modeling"],"prefix":"10.1016","volume":"317","author":[{"given":"Samrat","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apala","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biswajit","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shila Elizabeth","family":"Besra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saikat","family":"Dewanjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alankar","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramkrishna","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Probir Kumar","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapan Kumar","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanta","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mita Chatterjee","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miltu Kumar","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.121467_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111778","article-title":"Apigenin-loaded galactose tailored PLGA nanoparticles: a possible strategy for liver targeting to treat hepatocellular carcinoma","volume":"204","author":"Ganguly","year":"2021","journal-title":"Colloids Surf. B. Biointerfaces"},{"key":"10.1016\/j.lfs.2023.121467_bb0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2023.121467_bb0015","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1002\/cam4.4177","article-title":"Metabolic reprogramming of immune cells: shaping the tumor microenvironment in hepatocellular carcinoma","volume":"10","author":"Xia","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.lfs.2023.121467_bb0020","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41575-019-0217-8","article-title":"Metabolic rearrangements in primary liver cancers: cause and consequences","volume":"16","author":"Satriano","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.121467_bb0025","series-title":"Nanotherapeutics for the Treatment of Hepatocellular Carcinoma","first-page":"1","article-title":"Hepatocellular carcinoma: diagnosis, molecular pathogenesis, biomarkers, and conventional therapy","author":"Mukherjee","year":"2022"},{"key":"10.1016\/j.lfs.2023.121467_bb0030","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/ph14070656","article-title":"Insights into an immunotherapeutic approach to combat multidrug resistance in hepatocellular carcinoma","volume":"14","author":"Devan","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.lfs.2023.121467_bb0035","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.21037\/atm-2020-79","article-title":"Multikinase inhibitors to treat hepatocellular carcinoma failures to sorafenib-time has come for a better approach","volume":"8","author":"Alqahtani","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.lfs.2023.121467_bb0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lfs.2023.121467_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.114428","article-title":"Targeted therapy for hepatocellular carcinoma: challenges and opportunities","volume":"460","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2023.121467_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40364-021-00350-4","article-title":"Recent advances in systemic therapy for hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2022","journal-title":"Biomark Res."},{"key":"10.1016\/j.lfs.2023.121467_bb0055","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.18632\/oncotarget.23359","article-title":"Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma","volume":"9","author":"Ladju","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2023.121467_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.omtn.2020.01.034","article-title":"Aptamer-functionalized drug nanocarrier improves hepatocellular carcinoma toward normal by targeting neoplastic hepatocytes","volume":"20","author":"Chakraborty","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.lfs.2023.121467_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1208\/s12249-020-1629-z","article-title":"Comparative investigation of the ability of various aptamer-functionalized drug nanocarriers to induce selective apoptosis in neoplastic hepatocytes: in vitro and in vivo outcome","volume":"21","author":"Chakraborty","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.lfs.2023.121467_bb0070","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ijbiomac.2018.02.021","article-title":"Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles - a possibility for hepatic drug targeting: pharmacokinetics and biodistribution","volume":"11","author":"Mandal","year":"2018","journal-title":"Int. J. Bio. Macromol."},{"key":"10.1016\/j.lfs.2023.121467_bb0075","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1021\/acs.molpharmaceut.0c00977","article-title":"Apigenin-loaded PLGA-DMSA nanoparticles: a novel strategy to treat melanoma lung metastasis","volume":"18","author":"Sen","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.lfs.2023.121467_bb0080","first-page":"1578","article-title":"Apoptosis-inducing potentiality of Spathodea campanulata bark against hepatocellular carcinoma: HepG2 cells","volume":"9","author":"Kumar","year":"2021","journal-title":"WorldJ. Pharm. Res."},{"key":"10.1016\/j.lfs.2023.121467_bb0085","article-title":"Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma","volume":"34","author":"Paul","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.lfs.2023.121467_bb0090","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.2147\/IJN.S220740","article-title":"CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice","volume":"14","author":"Mondal","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.lfs.2023.121467_bb0095","first-page":"1","article-title":"Antisense oligonucleotides directed against insulin-like growth factor-II messenger ribonucleic acids delay the progress of rat hepatocarcinogenesis","volume":"13","author":"Ghosh","year":"2014","journal-title":"J. Carcinog."},{"key":"10.1016\/j.lfs.2023.121467_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112409","article-title":"Silybummarianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF\/c-Met, Wnt\/\u03b2-catenin, and PI3K\/Akt\/mTOR signaling pathways","volume":"145","author":"Yassin","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2023.121467_bb0105","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2174\/1573405612666160720123748","article-title":"Diagnostic imaging of hepatocellular carcinoma-a pictorial assay","volume":"13","author":"Nowicki","year":"2017","journal-title":"Curr. Med. Imaging Rev."},{"key":"10.1016\/j.lfs.2023.121467_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113205","article-title":"Carnosic acid, a naturally occurring antioxidant nutraceutical, decreases doxorubicin-induced cardiotoxicity by decreasing oxidative stress and its concomitant pathological consequences","volume":"166","author":"Manna","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2023.121467_bb0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/molecules26020258","article-title":"Myricitrin, a glycosyloxyflavone in Myrica esculenta bark ameliorates diabetic nephropathy via improving glycemic status,reducing oxidative stress, and suppressing inflammation","volume":"6","author":"Dua","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2023.121467_bb0120","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.3390\/ijms20082027","article-title":"Rosmarinic acid attenuates cadmium-induced nephrotoxicity via inhibition of oxidative stress. Apoptosis, inflammation and fibrosis","volume":"20","author":"Joardar","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121467_bb0125","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41598-017-00696-6","article-title":"Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies","volume":"7","author":"Gaonkar","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121467_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2008.12.008","article-title":"Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways","volume":"257","author":"Manna","year":"2009","journal-title":"Toxicol."},{"key":"10.1016\/j.lfs.2023.121467_bb0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejps.2017.07.032","article-title":"Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors","volume":"15","author":"den Braver-Sewradj","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2023.121467_bb0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"183","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121467_bb0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00280-009-1035-4","article-title":"Effect of antisense oligomer in controlling c-raf.1 overexpression during diethylnitrosamine-induced hepatocarcinogenesis in rat","volume":"65","author":"Das","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121467_bb0150","doi-asserted-by":"crossref","first-page":"21836","DOI":"10.1021\/acsami.8b04192","article-title":"Alleviating the liver toxicity of chemotherapy via pH-responsive hepatoprotective prodrug micelles","volume":"10","author":"Tao","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.lfs.2023.121467_bb0155","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein\u2013DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yumeng","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2023.121467_bb0160","author":"RCSB"},{"key":"10.1016\/j.lfs.2023.121467_bb0170","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.nano.2018.05.011","article-title":"Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats","volume":"14","author":"Bhattacharya","year":"2018","journal-title":"Nanomed."},{"key":"10.1016\/j.lfs.2023.121467_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/JHC.S106529","article-title":"Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies","volume":"4","author":"Galun","year":"2017","journal-title":"J. Heptocell. Carcinoma"},{"key":"10.1016\/j.lfs.2023.121467_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.114428","article-title":"Targeted therapy for hepatocellular carcinoma: challenges and opportunities","volume":"460","author":"Chena","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2023.121467_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1421438","article-title":"Carnosic acid, a natural diterpene, attenuates arsenic-induced hepatotoxicity via reducing oxidative stress, MAPK activation, and apoptotic cell death pathway","volume":"2018","author":"Das","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2023.121467_bb0190","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41467-018-02915-8","article-title":"Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2023.121467_bb0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/ijnm.IJNM_72_18","article-title":"Liver functional volumetry by Tc-99m mebrofenin hepatobiliary scintigraphy before major liver resection: a game changer","volume":"33","author":"Gupta","year":"2018","journal-title":"IndianJ. Nucl. Med."},{"key":"10.1016\/j.lfs.2023.121467_bb0200","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fimmu.2014.00307","article-title":"Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma","volume":"5","author":"Gehrmann","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.121467_bb0210","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.3892\/ol.2017.6531","article-title":"Heat shock protein 70 downregulation inhibits proliferation, migration and tumorigenicity in hepatocellular carcinoma cells","volume":"14","author":"Xiong","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2023.121467_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00391-18","article-title":"The Molecular chaperone heat shock protein 70 Controls liver cancer initiation and progression by regulating adaptive DNA damage and mitogen-activated protein kinase\/extracellular signal-regulated kinase signaling pathways","volume":"39","author":"Cho","year":"2019","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2023.121467_bb0220","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/ijc.29723","article-title":"Heat shock proteins in hepatocellular carcinoma: molecular mechanism and therapeutic potential","volume":"138","author":"Wang","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2023.121467_bb0225","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/1471-2407-14-425","article-title":"14\u20133-3\u03c3 induces heat shock protein 70 expression in hepatocellular carcinoma","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2023.121467_bb0230","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.omtn.2018.09.013","article-title":"Phosphorothioate-modified AP613-1 specifically target GPC3 when used for hepatocellular carcinoma imaging","volume":"13","author":"Dong","year":"2018","journal-title":"Mol. Ther. Nucleic. Acids"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:45:37Z","timestamp":1777423537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":44,"alternative-id":["S0024320523001017"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121467","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of superiority of HSP70-targeting aptamer-functionalized drug-nanocarrier over non-targeted commercially available counterpart in HCC therapy: in vitro and in vivo investigations and molecular modeling","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121467"}}